SCHEMBL20278787

SCHEMBL20278787

N[C@@H](CO)Cc1ncccc1C(F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 2/20 0.39
▸ EPHX2 P34913 1/20 0.37
▸ SSTR4 P31391 2/20 0.37
▸ SCN9A Q15858 2/20 0.36
▸ CD38 P28907 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CTNNB1 P35222 1/20 0.35
▸ WNT3A P56704 1/20 0.35
▸ ADORA2A P29274 1/20 0.34
▸ TRPM8 Q7Z2W7 1/20 0.34
▸ HSD17B13 Q7Z5P4 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ CXCL8 P10145 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ KLF5 Q13887 1/20 0.33
▸ HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20278780 0.79 L3MBTL1 (0.39) CXCR4ALDH1A1L3MBTL1ADORA2AKDM4E
SCHEMBL507101 0.78 ALDH1A1 (0.53) CXCR4EPHX2SSTR4CD38ALDH1A1
SCHEMBL20279321 0.77 L3MBTL1 (0.58) CXCR4ALDH1A1L3MBTL1KDM4E
SCHEMBL9963343 0.77 CXCR4 (0.45) CXCR4EPHX2SSTR4CD38CTNNB1
Hydrochloric Acid SCHEMBL2305254 0.76 ALDH1A1 (0.52) CXCR4EPHX2SSTR4CD38ALDH1A1
SCHEMBL20278969 0.76 ALDH1A1 (0.39) CXCR4ALDH1A1L3MBTL1KDM4EMEN1
SCHEMBL3959154 0.75 SSTR4 (0.46) CXCR4EPHX2SSTR4CD38ALDH1A1
SCHEMBL2301406 0.74 CXCR4 (0.45) CXCR4EPHX2SSTR4CD38ALDH1A1
SCHEMBL15827645 0.73 DPP4 (0.50) EPHX2SCN9AALDH1A1L3MBTL1
Hydrochloric Acid SCHEMBL16240453 0.73 CXCR4 (0.44) CXCR4EPHX2SSTR4CD38ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287251-B2 Pyrazole derivative or pharmaceutically acceptable salt thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20180170879-A1 PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2018-06-21 — — US disclosed
US-20180170879-A1 PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL CO., LTD. (JP) 2018-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10287251-B2 Pyrazole derivative or pharmaceutically acceptable salt thereof TRPM8, HCN3, HCN4 CXCR4 622/4885EPHX2 4636/4885SSTR4 418/4885
US-20180170879-A1 PYRAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TRPM8, HCN3, HCN4 CXCR4 651/4885EPHX2 4637/4885SSTR4 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback